Advice was provided to the Commission by the Australian Government Solicitors supplementary to the 2021 Privacy Impact Assessment. Its findings and recommendations are presented in this report.
This document provides information about the domains and indicators used in the EMM Self-Assessment Tool.
The purpose of the Electronic Medication Management Self-Assessment Tool User Guide (the Guide) is to support users of the Commission’s Electronic Medication Management Self-Assessment Tool (EMMSAT).
This fact sheet provides health service organisations with information about the Electronic Medication Management Self-Assessment Tool (EMMSAT). It describes how it can be used to support quality improvement activities to optimise implementation of electronic medication management (EMM).
A new National Sepsis Data Plan – Strategic Analysis Report released by the Commission envisions the future state of sepsis data in Australia.
Co-design is the practice of bringing healthcare consumers and professionals together to build a shared understanding of an issue and to work in equal partnership to create solutions.
This issue includes items on funding, reporting, climate change, engagement, cognitive impairment, social connection, sepsis, and more. Along with the latest from BMJ Quality & Safety.
The Commission released the latest draft of the National Safety and Quality Medical Imaging Standards (draft Standards) in December 2025, ahead of a regulatory impact assessment.
In early 2026, health economists will contact stakeholders to gather feedback as part of the Cost Benefit Analysis (CBA) process. We expect the Standards to be implemented in early 2028.
We are excited to introduce the new GP Snapshot on Chronic Obstructive Pulmonary Disease (COPD) Pharmacological Management.
The Commission has reviewed and updated the Diagnostic Imaging Accreditation Scheme (DIAS) Advisory D121/04: Disinfection requirements for reusable medical devices.